Xylazine anased equn 100MG/ML 50ML and 2 more items

The University of Virginia awarded a purchase order (PO-0480660) to WA Butler Company, doing business as Covetrus North America, LLC on September 16, 2026, for the procurement of veterinary pharmaceutical products. The contract, valued at $43.74, encompasses three line items including xylazine anased equine 100 milligrams per milliliter in a 50-milliliter bottle ($20.87), ketamine hydrochloride 100 milligrams per milliliter in a 10-milliliter bottle—a controlled substance ($6.87), and freight services ($16.00). All materials are designated for delivery to Charles Mitchell Boudreaux.

This procurement represents a routine purchase of equine anesthesia and sedation pharmaceuticals required by the University of Virginia. The award demonstrates the institution's utilization of Covetrus North America, LLC as a qualified supplier for controlled and non-controlled veterinary medications. The contract's modest cumulative value and single-unit quantities indicate this is a direct purchase order rather than a blanket or requirements-based agreement.